5 results match your criteria: "The Shandong Provincial Third Hospital[Affiliation]"
Asian J Surg
July 2024
Department of Oral and Maxillofacial Reconstruction, The Affiliated Hospital of Qingdao University, Qingdao, 266555, China; Key Lab of Oral Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, 266555, China; Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266555, China. Electronic address:
Asian J Surg
May 2024
The Department of Urology, The Shandong Provincial Third Hospital, Shandong University, No.11 Wuyingshan Middle Road, Tianqiao District, Jinan, Shandong, 250031, PR China. Electronic address:
Asian J Surg
October 2023
The Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, PR China. Electronic address:
Crit Rev Eukaryot Gene Expr
July 2021
Department of Health Management, The Shandong Provincial Third Hospital, No. 11, Wuyingshan Road, Tianqiao District, Jinan 250031, Shandong, China.
This article serves to evaluate the association of polymorphisms of mismatch repair genes (hMLH1 and hMSH2) with breast cancer (BC) susceptibility through a meta-analysis. Our methods involved extensive research in Chinese and English databases that examined the association of hMLH1 and hMSH2 polymorphisms with susceptibility to BC, strictly abiding by established inclusion and exclusion criteria. Software Stata 12.
View Article and Find Full Text PDFZhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
December 2019
Department of Orthopaedics, the Shandong Provincial Third Hospital, Jinan Shandong, 250031, P.R.China.
Objective: To investigate the effectiveness of extracorporeal shock wave therapy combined with platelet-rich plasma (PRP) injection in treatment of knee osteoarthritis (KOA) by prospective clinical study.
Methods: Between June 2015 and June 2018, 180 patients with KOA met the inclusion criteria were included in study and randomly allocated to group A (=60), group B (=60), and group C (=60). The patients were treated with autologous PRP intra-articular injection in group A, extracorporeal shock wave therapy in group B, and extracorporeal shock wave therapy combined with autologous PRP intra-articular injection in group C, once a week and 5 times a duration of treatment.